​
​

SAB Biotherapeutics (SABS) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

SAB Biotherapeutics Revenue Highlights

Latest Revenue (Y)

$2.24M

Latest Revenue (Q)

$263.14K

Main Segment (Y)

Grant Revenue

Main Geography (Y)

Grant Revenue

SAB Biotherapeutics Revenue by Period

SAB Biotherapeutics Revenue by Year

DateRevenueChange
2023-12-31$2.24M-90.63%
2022-12-31$23.90M-60.73%
2021-12-31$60.88M10.21%
2020-12-31$55.24M1504.91%
2019-12-31$3.44M-

SAB Biotherapeutics generated $2.24M in revenue during NA 2023, up -90.63% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

SAB Biotherapeutics Revenue by Quarter

DateRevenueChange
2024-06-30$263.14K-72.14%
2024-03-31$944.58K209.69%
2023-12-31$305.01K-75.93%
2023-09-30$1.27M1381.98%
2023-06-30$85.52K-85.28%
2023-03-31$581.10K-73.11%
2022-12-31$2.16M-39.80%
2022-09-30$3.59M-43.47%
2022-06-30$6.35M-46.20%
2022-03-31$11.80M-80.61%
2021-12-31$60.88M100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31--

SAB Biotherapeutics generated $263.14K in revenue during Q2 2024, up -72.14% compared to the previous quarter, and up 45.28% compared to the same period a year ago.

SAB Biotherapeutics Revenue Breakdown

SAB Biotherapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 21
Grant Revenue$60.88M

SAB Biotherapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 21: Grant Revenue (100.00%).

Quarterly Revenue by Product

Product/ServiceSep 22Jun 22Mar 22
Grant Revenue$3.59M$6.35M$11.80M

SAB Biotherapeutics's latest quarterly revenue breakdown by segment (product or service), as of Sep 22: Grant Revenue (100.00%).

SAB Biotherapeutics Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 21
Grant Revenue$60.88M

SAB Biotherapeutics's latest annual revenue breakdown by geography, as of Dec 21: Grant Revenue (100.00%).

Quarterly Revenue by Country

CountrySep 22Jun 22Mar 22
Grant Revenue$3.59M$6.35M$11.80M

SAB Biotherapeutics's latest quarterly revenue breakdown by geography, as of Sep 22: Grant Revenue (100.00%).

SAB Biotherapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
FRTXFresh Tracks Therapeutics$8.01M-
SABSSAB Biotherapeutics$2.24M$263.14K
UNCYUnicycive Therapeutics$675.00K-
VRAXVirax Biolabs Group$8.56K$76.50K
ANEBAnebulo Pharmaceuticals--
PXMDPaxMedica--
PCSAProcessa Pharmaceuticals--
CVKDCadrenal Therapeutics--
MNPRMonopar Therapeutics--
THRDThird Harmonic Bio--
QNRXQuoin Pharmaceuticals--
CDIOCardio Diagnostics-$6.58K

SABS Revenue FAQ

What is SAB Biotherapeutics’s yearly revenue?

SAB Biotherapeutics's yearly revenue for 2023 was $2.24M, representing a decrease of -90.63% compared to 2022. The company's yearly revenue for 2022 was $23.9M, representing a decrease of -60.73% compared to 2021. SABS's yearly revenue for 2021 was $60.88M, representing an increase of 10.21% compared to 2020.

What is SAB Biotherapeutics’s quarterly revenue?

SAB Biotherapeutics's quarterly revenue for Q2 2024 was $263.14K, a -72.14% decrease from the previous quarter (Q1 2024), and a 207.70% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $944.58K, a 209.69% increase from the previous quarter (Q4 2023), and a 62.55% increase year-over-year (Q1 2023). SABS's quarterly revenue for Q4 2023 was $305.01K, a -75.93% decrease from the previous quarter (Q3 2023), and a -85.88% decrease year-over-year (Q4 2022).

What is SAB Biotherapeutics’s revenue growth rate?

SAB Biotherapeutics's revenue growth rate for the last 3 years (2021-2023) was -96.32%, and for the last 5 years (2019-2023) was -34.95%.

What are SAB Biotherapeutics’s revenue streams?

SAB Biotherapeutics's revenue streams in c 21 are Grant Revenue

What is SAB Biotherapeutics’s main source of revenue?

For the fiscal year ending Dec 21, the largest source of revenue of SAB Biotherapeutics was Grant Revenue. This segment made a revenue of $60.88M, representing 100.00% of the company's total revenue.